Research by the Journal of the American Medical Association (JAMA) indicated that 48% of selective androgen receptor modulators (SARMs) are either counterfeit, inadequately dosed, or substituted with inexpensive and hazardous substances (1). Although studies have shown SARMs to have anabolic effects (2), acquiring them is risky due to their unregulated nature (3). Consequently, numerous rogue […]
